API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/main-products-inc-issues-voluntary-nationwide-recall-umary-acido-hialuronico-suplemento-alimenticio
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/solovitalcom-issues-voluntary-nationwide-recall-umary-acido-hialuronica-suplemento-alimenticio-850
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-6-2024-62498.pdf
https://www.prnewswire.com/news-releases/redhill-announces-new-uspto-patent-grant-for-talicia-for-h-pylori-treatment-through-2042-302044556.html
https://www.pharmacompass.com/pdf/news/successful-pivotal-bioequivalence-study-results-on-omeprazole-immediate-release-capsules-22335.pdf
https://www.pharmaceutical-technology.com/news/fda-approval-azurity-konvomep/
https://www.prnewswire.com/news-releases/new-study-confirms-that-a-commonly-used-acid-reducing-drug-does-not-interfere-with-the-absorption-of-a-novel-liquid-levothyroxine-formulation-301390136.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-31-2021-1617172039.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-24-2021-1616562985.pdf
https://blogs.sciencemag.org/pipeline/archives/2020/04/13/omeprazole-as-an-additive-for-coronavirus-therapy
https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-sandoz-limited-omeprazole-40-mg-powder-for-solution-for-infusion-pl-04416-0701-el-19-a-34
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/now-antacids-must-carry-kidney-injury-warning/articleshow/71933520.cms
https://www.fiercepharma.com/manufacturing/need-a-safe-antacid-for-heartburn-fda-declares-pepcid-nexium-and-others-free-ndma
https://endpts.com/as-its-oncology-effort-gathers-steam-astrazeneca-sheds-another-legacy-drug/
https://www.reuters.com/article/us-astrazeneca-divestiture/astrazeneca-sells-acid-reflux-drug-rights-to-germanys-cheplapharm-idUSKBN1WG32A
https://www.fiercepharma.com/marketing/modern-drug-launch-consultancy-promotes-new-go-to-market-digital-strategy-for-small-to
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209660
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-6-2019-1549474146.pdf
https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-afda-orgs/documents/document/ucm629123.pdf
https://health.economictimes.indiatimes.com/news/pharma/dr-reddys-launches-heartburn-drug-in-us-market/67041961
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207740
https://www.ema.europa.eu/documents/chmp-annex/start-community-reviews-chmp-meeting-15-18-october-2018_en.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205070
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-fixes-prices-of-22-drug-formulations/articleshow/64575442.cms
https://www.prnewswire.com/news-releases/novaquest-capital-management-acquires-cutispharma-inc-300619121.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203345
http://www.pharmatimes.com/news/number_of_prescriptions_rises_as_net_ingredient_cost_falls_1227875
https://www.pharmacompass.com/pdf/news/top-selling-top-prescribed-drugs-for-2016-1507784462.pdf
http://www.raps.org/Regulatory-Focus/News/2017/07/13/28078/FDA-Publishes-21-New-13-Revised-Draft-Generic-Drug-Guidances/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
https://www.pharmacompass.com/pdf/news/anvisa-suspends-eurofarmas-batch-of-omeprazole-1499747950.pdf
http://edition.cnn.com/2017/07/03/health/proton-pump-inhibitors-early-death-risk-study/index.html
http://www.reuters.com/article/us-health-aspirin-idUSKBN1942ZB
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204661
https://www.pharmacompass.com/pdf/news/pendopharm-issues-recall-of-olex-due-the-affected-lots-may-be-out-of-specification-for-impurities-1491891455.pdf
https://www.pharmacompass.com/pdf/news/pharmascience-inc-issues-recall-of-personnelle-omeprazole-due-to-the-affected-lots-may-be-out-of-specification-for-impurities-1491892480.pdf
https://www.pharmacompass.com/pdf/news/omeprazole-dexcel-v-apotex-1494841587.pdf
http://www.cbsnews.com/news/heartburn-acid-reflux-drugs-ppi-associated-with-increased-risk-kidney-damage/
http://www.fiercepharma.com/marketing/gsk-debuts-new-fireball-character-for-prevacid-otc-heartburn-drug
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207476
http://www.fiercepharma.com/pharma/look-out-valeant-horizon-et-al-payers-patients-target-pricey-meds-combo-cheap-generics
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/60306r-eng.php
http://www.pharma-excipients.ch/2016/08/09/conversion-of-sustained-release-omeprazole-loaded-buccal-films-into-fast-dissolving-strips-using-supercritical-carbon-dioxide-scco2-processing-for-potential-paediatric-drug-delivery/
https://www.pharmacompass.com/pdf/news/anvisa-suspended-ach-sas-sibutramine-hydrochloride-omeprazole-1470379564.pdf
http://www.prnewswire.com/news-releases/perrigo-announces-fda-final-approval-and-launch-of-the-store-brand-equivalent-to-zegerid-otc-capsules-300299858.html
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ajanta-pharma-launches-acid-reflux-drug-in-us/articleshow/53263828.cms
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-launches-generic-acid-reflux-drug-in-us/articleshow/53269757.cms
https://www.pharmacompass.com/pdf/news/ajanta-pharmas-acid-reflux-drug-approved-in-us-1469101876.pdf